NOVARTIS BASEL AKT (NVSEF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 28 150 sessions, October 20, 2025 to October 21, 2026
- Largest daily move
- -15.7% close of September 9, 2026
- 1-year change
- +11.7% closing prices, October 20, 2025 to October 21, 2026
- 1-month change
- +5.7% closing prices, September 21, 2026 to October 21, 2026
Company Description
NVSEF has gained 11.7% over the past year. The last closing price was $146.18.
For FY2025, NOVARTIS BASEL AKT reported revenue of $56.7B with net income of $14.0B and diluted earnings per share of $7.15. The company operates at a net profit margin of 24.7%.
This page collects what Stock Titan holds for NVSEF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
NOVARTIS BASEL AKT (NVSEF) closed at $146.18 on October 21, 2026. Over the past 12 months, the price has gained 11.7%.
NVSEF Metrics & Rankings
Price returns through October 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
NOVARTIS BASEL AKT has filed 10 recent SEC filings, including 7 Form 6-K, 3 Form 144. The most recent filing was submitted on September 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NVSEF SEC filings →
Financial Highlights
NOVARTIS BASEL AKT generated $56.7B in revenue in FY2025, retaining a 75.8% gross margin, operating income reached $17.6B (31.1% operating margin), and net income was $14.0B, reflecting a 24.7% net profit margin. Diluted earnings per share stood at $7.15. The company generated $19.1B in operating cash flow. The current ratio was 1.12, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in NOVARTIS BASEL AKT (NVSEF) currently stands at 1.6 million shares, up 41.2% from the previous reporting period, representing 0.1% of the float.
Days to Cover History
Days to cover for NOVARTIS BASEL AKT (NVSEF) currently stands at 21.4 days, up 30.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 21.4%. Across the settlements charted above, it has ranged from 4.4 to 1000.0 days.